Recruiting Mesothelioma Studies in Philadelphia
About Mesothelioma Clinical Trials in Philadelphia
Mesothelioma is a rare cancer that develops in the thin tissue lining the lungs, abdomen, or heart, primarily caused by asbestos exposure. Most cases are pleural mesothelioma affecting the lung lining. Treatment includes surgery, chemotherapy, radiation, and immunotherapy.
There are currently 2 mesothelioma clinical trials recruiting participants in Philadelphia, PA. These studies are seeking a combined 120 participants. Research is being sponsored by InSilico Medicine Hong Kong Limited, Abramson Cancer Center at Penn Medicine. Clinical trial participation is free and participants receive study-related medical care at no cost.
Mesothelioma Clinical Trials in Philadelphia — FAQ
Are there mesothelioma clinical trials in Philadelphia?
Yes, there are 2 mesothelioma clinical trials currently recruiting in Philadelphia, PA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Philadelphia?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Philadelphia research site will contact you about next steps.
Are clinical trials in Philadelphia free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Philadelphia studies also compensate for your time and travel.
What mesothelioma treatments are being tested?
The 2 active trials in Philadelphia are testing new therapies including novel drugs, biologics, and treatment approaches for mesothelioma.
Data updated July 13, 2026 from ClinicalTrials.gov